Transforming Lives: How a Clinical Trial Enhanced My Comfort and Well-Being

Irwin Hausman’s journey with metastatic pancreatic cancer began on August 16, 2015, when he was diagnosed at the age of 72. With a history of good health, the news was a shocking blow. After being treated at Mount Sinai Hospital in New York City, Irwin’s situation seemed bleak as his cancer had spread to his liver, making surgery impossible. However, his oncologist, Dr. Howard Bruckner from the Bronx, was determined to explore alternative options rather than resigning to despair.

Innovative Approach: Clinical Trial with Vitamin C

Under Dr. Bruckner’s care, Irwin became part of a groundbreaking clinical trial that combined low-dose chemotherapy with vitamin C infusions. This unique method involved administering lower doses of traditional chemotherapy drugs compared to what is typically offered at most cancer treatment centers.

• Enhanced Comfort: The treatment allowed Irwin to enjoy a year of relative comfort.
• Active Lifestyle: He maintained an active lifestyle, playing golf two to three times a week.
• Tumor Progression: Remarkably, the tumors in his liver showed signs of reduction, while the pancreatic tumor remained stable, hinting at a positive response to the combined therapy.

Surgery on the Horizon?

Now, Irwin is contemplating the possibility of surgery. While he understands that surgery may still not be an option, the combination of chemotherapy and vitamin C appears to be yielding positive results. His quality of life has improved significantly, bringing him happiness that seemed unattainable just a year prior.

Irwin expresses immense gratitude toward Dr. Bruckner, whom he describes as a visionary in oncology, always striving for innovative solutions that promote not just survival, but a comfortable and fulfilling life.

For further insights into the clinical trial that Irwin participated in, consider reading more about “Using a Vitamin to Enhance Low-Dose Chemotherapy Effectiveness.”

Legacy and Impact

Irwin’s story serves not only as a testament to the power of innovative treatments but also as a beacon of hope for others facing similar challenges. His commitment to participating in clinical trials has contributed to a broader understanding of treatment options for pancreatic cancer.

Irwin’s journey ended after he shared his inspiring story, but his legacy lives on, offering support and knowledge to those who follow in his footsteps. Our heartfelt condolences go out to his family during this difficult time.

If you or someone you know is seeking information on clinical trials, you can find helpful resources on how to navigate this process here.